Anavex Life Sciences (AVXL) News
NASDAQ: AVXLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.49-0.05 (-3.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AVXL news summary
We found 1 recent headline mentioning Anavex Life Sciences (AVXL): 1 in the past week and 1 in the past 30 days, most often from PR Newswire. For price context, AVXL is down 3.25% at $1.49. The most recent story, "AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm", was published by PR Newswire on Oct 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology